Ryvyl (NasdaqCM:RVYL) 2026 Extraordinary General Meeting March 25, 2026 04:00 PM ET Company ParticipantsGeorge Oliva - Interim CEO, CFO, and DirectorGeorge OlivaGood afternoon, and welcome to the postponed special meeting of stockholders of Ryvyl Inc. Thank you all for joining us today. I am George Oliva, Interim CEO and CFO, and a Director of Ryvyl Inc. I'll be serving as the Chair of today's special meeting of stockholders. Jasmine Farrington will serve as Secretary of the meeting. We are pleased to again ...

Investor Presentation Third Quarter FY26 NASDAQ: MLKN Forward looking statements or operating results. or financial condition or the price of our stock. import. – Global and national economic conditions such as heightened inflation, uncertainty regarding future interest rates, foreign currency exchange rate fluctuations, the escalating conflict in the Middle East, the continuation of the Russia-Ukraine war, and potential governmental responses to these events; – Cybersecurity threats and risks; – Public hea ...

An AI-Powered Marketplace Platform Helping SMBs Access Better Self-Funded Health Plans Disclaimer & Safe Harbor This presentation has been prepared by the Health In Tech, Inc. (the "Company," "Health In Tech," "HIT," "we," "our," or "us") solely for informational purposes. The information included herein in this presentation has not been independently verified. No representations, warranties or undertakings, express or implied, are made by the Company or any of its affiliates, advisers or representatives as ...

Investor Presentation Q4 Fiscal 2026 Safe Harbor Disclaimer This presentation contains "forward-looking statementsˮ within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding Navan's anticipated total revenue, non-GAAP income (loss) from operations, and non-GAAP operating margin for the fiscal quarter ending April 30, 2026 and fiscal year ending January 31, 2027, the size of Navan's market opportunity, market trends, and the company's busi ...

Peraso (NasdaqCM:PRSO) Conference March 25, 2026 02:30 PM ET Company ParticipantsJim Sullivan - CFORon Glibbery - CEO and Co-FounderJim SullivanWe'll move right through to the first slide and get you going.Ron GlibberyOkay. There we go. Peraso is a fabless semiconductor company. I just read today that the top seven of the top 25 companies in the world are semiconductor companies, so we're in good company. Basically we focus on wireless technology, and our specific focus is on 60 gigahertz millimeter wave, w ...

Zeo Energy (NasdaqCM:ZEO) Conference March 25, 2026 01:30 PM ET Company ParticipantsCannon Holbrook - CFOTimothy Bridgewater - CEOTimothy BridgewaterCEO of Zeo Energy, a NASDAQ-listed company. We are in the residential solar business primarily. You can see it from our picture on our investor deck slide. We sell, install, and service residential solar systems, and I'll go into a little more detail about our business. This is the safe harbor forward-looking statements, and just to make sure that whatever we p ...

Nautilus Biotechnology (NasdaqGS:NAUT) Conference March 25, 2026 01:00 PM ET Company ParticipantsAnna Mowry - CFOSujal Patel - Founder and CEOSujal PatelHello, everyone. I'm Sujal Patel, Founder and CEO of Nautilus Biotechnology, and I'm joined with by Anna Mowry, our Chief Financial Officer. We're here to talk about Nautilus unlocking the power of the proteome to revolutionize biomedicine. As we begin, this is our standard safe harbor statement. This presentation and my oral remarks have forward-looking st ...

Denali Therapeutics (NasdaqGS:DNLI) Update / briefing March 25, 2026 12:30 PM ET Company ParticipantsAlexander Schuth - CFO and COOAndrew Tsai - Managing DirectorJohn Kreger - Director of ResearchKatie Peng - Chief Commercial OfficerLaura Chico - Managing Director of Equity ResearchLaura Hansen - VP of Investor RelationsLydia Erdman - Biotech Equity Research AssociateMayank Mamtani - Senior Managing Director and Group Head of HealthcareMike Riad - VPPeter Chin - Chief Medical OfficerPeyton Bohnsack - VP of ...

Denali Therapeutics (NasdaqGS:DNLI) Update / briefing March 25, 2026 12:30 PM ET Speaker8Reminder, today's program is being recorded. Now I'd like to introduce your host for today's program, Laura Hansen, Vice President of Investor Relations. Please go ahead.Speaker4Thank you, Jonathan, and good day, everyone. Thank you for joining us today for our AVLAYAH FDA approval conference call. I'm Laura Hansen, Vice President of Investor Relations at Denali Therapeutics. Joining me on the call today are Ryan Watts, ...

NeoVolta (NasdaqCM:NEOV) Conference March 25, 2026 12:00 PM ET Company ParticipantsSteve Bond - CFO and Co-FounderSteve BondGood morning, everyone. My name is Steve Bond. I'm the CFO and co-founder of NeoVolta. Ardes Johnson was scheduled to present, but he is in the TSA traveling to Washington, D.C., so I'll take it from here. I founded NeoVolta in 2018 with a group of partners in Southern California. We have always been an energy storage technology company, and I'm gonna tell you the story that spans two ...